These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 35319387)

  • 21. 1-(3-aminomethyl-4-hydroxyphenyl)-3-pyridinyl-2-propen-1-ones: a novel group of tumour-selective cytotoxins.
    Bilginer S; Gul HI; Mete E; Das U; Sakagami H; Umemura N; Dimmock JR
    J Enzyme Inhib Med Chem; 2013 Oct; 28(5):974-80. PubMed ID: 22803675
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis and biological evaluation of 1,5-bis(4-hydroxy-3-methoxyphenyl)penta-1,4-dien-3-one and its aminomethyl derivatives.
    Yerdelen KO; Gul HI; Sakagami H; Umemura N
    J Enzyme Inhib Med Chem; 2015 Jun; 30(3):383-8. PubMed ID: 25068729
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel 3,5-bis(arylidene)-4-piperidone dimers: potent cytotoxins against colon cancer cells.
    Das S; Das U; Michel D; Gorecki DK; Dimmock JR
    Eur J Med Chem; 2013 Jun; 64():321-8. PubMed ID: 23644215
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Design, synthesis and cytotoxic properties of novel 1-[4-(2-alkylaminoethoxy)phenylcarbonyl]-3,5-bis(arylidene)-4-piperidones and related compounds.
    Das U; Alcorn J; Shrivastav A; Sharma RK; De Clercq E; Balzarini J; Dimmock JR
    Eur J Med Chem; 2007 Jan; 42(1):71-80. PubMed ID: 16996657
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dimeric 3,5-bis(benzylidene)-4-piperidones: a novel cluster of tumour-selective cytotoxins possessing multidrug-resistant properties.
    Das S; Das U; Sakagami H; Umemura N; Iwamoto S; Matsuta T; Kawase M; Molnár J; Serly J; Gorecki DK; Dimmock JR
    Eur J Med Chem; 2012 May; 51():193-9. PubMed ID: 22409967
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Discovery and Investigation of 1-[4-(2-Aminoethoxy)Phenylcarbonyl]- 3,5-Bis-(Benzylidene)-4-Piperidones as Candidate Antineoplastic Agents: Our Last 15 Years Study.
    Hossain M; Enci CE; Dimmock JR; Das U
    Curr Med Chem; 2021; 28(13):2453-2464. PubMed ID: 32744955
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cytotoxic evaluation of some N-acyl and N-acyloxy analogues of 3,5-bis(arylidene)-4-piperidones.
    Dimmock JR; Arora VK; Chen M; Allen TM; Kao GY
    Drug Des Discov; 1994 Jul; 12(1):19-28. PubMed ID: 7578805
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Design, synthesis and antiproliferative activity of some 3-benzylidene-2,3-dihydro-1-benzopyran-4-ones which display selective toxicity for malignant cells.
    Perjési P; Das U; De Clercq E; Balzarini J; Kawase M; Sakagami H; Stables JP; Lorand T; Rozmer Z; Dimmock JR
    Eur J Med Chem; 2008 Apr; 43(4):839-45. PubMed ID: 17692998
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 1-Aryl-2-dimethylaminomethyl-2-propen-1-one hydrochlorides and related adducts: A quest for selective cytotoxicity for malignant cells.
    Pati HN; Das U; Kawase M; Sakagami H; Balzarini J; De Clercq E; Dimmock JR
    Bioorg Med Chem; 2008 May; 16(10):5747-53. PubMed ID: 18397829
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CoMFA and CoMSIA studies on 1,3-bis(benzylidene)-3,4-dihydro-1H-naphthalen-2-one, 2,6-bis(benzylidene)cyclohexanone, and 3,5-bis(benzylidene)-4-piperidone series of cytotoxic compounds.
    Patel MR; Dimmock JR; Talele TT
    J Chem Inf Model; 2007; 47(6):2110-23. PubMed ID: 17944456
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel Curcumin Inspired Antineoplastic 1-Sulfonyl-4-Piperidones: Design, Synthesis and Molecular Modeling Studies.
    Fawzy NG; Panda SS; Fayad W; El-Manawaty MA; Srour AM; Girgis AS
    Anticancer Agents Med Chem; 2019; 19(8):1069-1078. PubMed ID: 30961509
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis of 2-Substituted 4-Arylidene-5(4H)-oxazolones as Potential Cytotoxic Agents in the Presence of Lemon Juice as a Biocatalyst.
    Prasad MG; Lakshmi CV; Katari NK; Anand K; Pal M; Jonnalagadda SB
    Comb Chem High Throughput Screen; 2019; 22(9):625-634. PubMed ID: 31696809
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The cytotoxic properties and preferential toxicity to tumour cells displayed by some 2,4-bis(benzylidene)-8-methyl-8-azabicyclo[3.2.1] octan-3-ones and 3,5-bis(benzylidene)-1-methyl-4-piperidones.
    Pati HN; Das U; Das S; Bandy B; De Clercq E; Balzarini J; Kawase M; Sakagami H; Quail JW; Stables JP; Dimmock JR
    Eur J Med Chem; 2009 Jan; 44(1):54-62. PubMed ID: 18468733
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Design, synthesis and bioevaluation of novel N-substituted-3,5-bis(arylidene)-4-piperidone derivatives as cytotoxic and antitumor agents with fluorescent properties.
    Sun J; Zhang S; Yu C; Hou G; Zhang X; Li K; Zhao F
    Chem Biol Drug Des; 2014 Apr; 83(4):392-400. PubMed ID: 24148151
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A conformational and structure-activity relationship study of cytotoxic 3,5-bis(arylidene)-4-piperidones and related N-acryloyl analogues.
    Dimmock JR; Padmanilayam MP; Puthucode RN; Nazarali AJ; Motaganahalli NL; Zello GA; Quail JW; Oloo EO; Kraatz HB; Prisciak JS; Allen TM; Santos CL; Balzarini J; De Clercq E; Manavathu EK
    J Med Chem; 2001 Feb; 44(4):586-93. PubMed ID: 11170648
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A novel class of piperidones exhibit potent, selective and pro-apoptotic anti-leukemia properties.
    Nunes LM; Hossain M; Varela-Ramirez A; DAS U; Ayala-Marin YM; Dimmock JR; Aguilera RJ
    Oncol Lett; 2016 Jun; 11(6):3842-3848. PubMed ID: 27313705
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis, antitumor activity evaluation of some new N-aroyl-α,β-unsaturated piperidones with fluorescence.
    Sun J; Wang S; Li H; Jiang W; Hou G; Zhao F; Cong W
    J Enzyme Inhib Med Chem; 2016; 31(3):495-502. PubMed ID: 26382011
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis of N-substituted 3,5-bis(arylidene)-4-piperidones with high antitumor and antioxidant activity.
    Kálai T; Kuppusamy ML; Balog M; Selvendiran K; Rivera BK; Kuppusamy P; Hideg K
    J Med Chem; 2011 Aug; 54(15):5414-21. PubMed ID: 21702507
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative QSAR Analysis of 3,5-bis (Arylidene)-4-Piperidone Derivatives: the Development of Predictive Cytotoxicity Models.
    Edraki N; Das U; Hemateenejad B; Dimmock JR; Miri R
    Iran J Pharm Res; 2016; 15(2):425-37. PubMed ID: 27642313
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 1-[3-(2-Hydroxyethylsulfanyl)propanoyl]-3,5-bis(benzylidene)-4-piperidones: A novel cluster of P-glycoprotein dependent multidrug resistance modulators.
    Das U; Pati HN; Baráth Z; Csonka Á; Molnár J; Dimmock JR
    Bioorg Med Chem Lett; 2016 Feb; 26(4):1319-21. PubMed ID: 26796064
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.